These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11865283)
1. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a. Bandsma RH; Rake JP; Visser G; Neese RA; Hellerstein MK; van Duyvenvoorde W; Princen HM; Stellaard F; Smit GP; Kuipers F J Pediatr; 2002 Feb; 140(2):256-60. PubMed ID: 11865283 [TBL] [Abstract][Full Text] [Related]
2. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Bandsma RH; Prinsen BH; van Der Velden Mde S; Rake JP; Boer T; Smit GP; Reijngoud DJ; Kuipers F Pediatr Res; 2008 Jun; 63(6):702-7. PubMed ID: 18520334 [TBL] [Abstract][Full Text] [Related]
3. [Blood lipids and metabolic diseases]. Benedetti A; Noacco C G Clin Med; 1978; 59(7-8):304-9. PubMed ID: 216601 [No Abstract] [Full Text] [Related]
4. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III. Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362 [TBL] [Abstract][Full Text] [Related]
6. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Nguyen AD; Pan CJ; Weinstein DA; Chou JY Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453 [TBL] [Abstract][Full Text] [Related]
7. The hyperlipidemia in glycogen storage disease. Jakovcic S; Khachadurian AK; Hsia DY J Lab Clin Med; 1966 Nov; 68(5):769-79. PubMed ID: 5223987 [No Abstract] [Full Text] [Related]
8. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]
9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference. Niu YG; Evans RD Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778 [TBL] [Abstract][Full Text] [Related]
11. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
12. Anthocyanins increase low-density lipoprotein and plasma cholesterol and do not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits. Finné Nielsen IL; Elbøl Rasmussen S; Mortensen A; Ravn-Haren G; Ma HP; Knuthsen P; Hansen BF; McPhail D; Freese R; Breinholt V; Frandsen H; Dragsted LO Mol Nutr Food Res; 2005 Apr; 49(4):301-8. PubMed ID: 15759306 [TBL] [Abstract][Full Text] [Related]
13. Plasma and lipoprotein fatty acid composition in glycogen storage disease type I. Levy E; Letarte J; Lepage G; Thibault L; Roy CC Lipids; 1987 Jun; 22(6):381-5. PubMed ID: 3475522 [TBL] [Abstract][Full Text] [Related]
14. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628 [TBL] [Abstract][Full Text] [Related]
15. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia. Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378 [TBL] [Abstract][Full Text] [Related]
16. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia]. Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587 [TBL] [Abstract][Full Text] [Related]